RMQAX vs. BIPIX
Compare and contrast key facts about Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund (RMQAX) and ProFunds Biotechnology UltraSector Fund (BIPIX).
RMQAX is managed by Rydex Funds. It was launched on Nov 27, 2014. BIPIX is managed by ProFunds. It was launched on Jun 18, 2000.
Performance
RMQAX vs. BIPIX - Performance Comparison
Loading graphics...
RMQAX vs. BIPIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RMQAX Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund | -19.02% | 33.92% | 44.76% | 115.91% | -59.93% | 56.36% | 101.06% | 80.80% | -7.28% | 69.80% |
BIPIX ProFunds Biotechnology UltraSector Fund | -5.32% | 47.99% | -5.81% | 9.55% | -13.43% | 5.00% | 19.94% | 23.65% | -12.15% | 34.71% |
Returns By Period
In the year-to-date period, RMQAX achieves a -19.02% return, which is significantly lower than BIPIX's -5.32% return. Over the past 10 years, RMQAX has outperformed BIPIX with an annualized return of 30.14%, while BIPIX has yielded a comparatively lower 8.28% annualized return.
RMQAX
- 1D
- -1.68%
- 1M
- -16.37%
- YTD
- -19.02%
- 6M
- -16.53%
- 1Y
- 31.63%
- 3Y*
- 33.85%
- 5Y*
- 15.55%
- 10Y*
- 30.14%
BIPIX
- 1D
- -0.99%
- 1M
- -10.46%
- YTD
- -5.32%
- 6M
- 26.06%
- 1Y
- 66.71%
- 3Y*
- 16.68%
- 5Y*
- 4.74%
- 10Y*
- 8.28%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RMQAX vs. BIPIX - Expense Ratio Comparison
RMQAX has a 1.32% expense ratio, which is lower than BIPIX's 1.49% expense ratio.
Return for Risk
RMQAX vs. BIPIX — Risk / Return Rank
RMQAX
BIPIX
RMQAX vs. BIPIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund (RMQAX) and ProFunds Biotechnology UltraSector Fund (BIPIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RMQAX | BIPIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.67 | 1.34 | -0.67 |
Sortino ratioReturn per unit of downside risk | 1.28 | 1.89 | -0.60 |
Omega ratioGain probability vs. loss probability | 1.18 | 1.24 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 0.96 | 2.12 | -1.16 |
Martin ratioReturn relative to average drawdown | 3.36 | 7.76 | -4.40 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RMQAX | BIPIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.67 | 1.34 | -0.67 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.34 | 0.13 | +0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.65 | 0.24 | +0.42 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.62 | 0.17 | +0.45 |
Correlation
The correlation between RMQAX and BIPIX is 0.60, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
RMQAX vs. BIPIX - Dividend Comparison
RMQAX's dividend yield for the trailing twelve months is around 44.79%, more than BIPIX's 0.39% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RMQAX Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund | 44.79% | 36.27% | 26.02% | 3.76% | 0.00% | 2.18% | 5.30% | 0.10% | 0.00% | 0.00% |
BIPIX ProFunds Biotechnology UltraSector Fund | 0.39% | 0.37% | 28.81% | 6.69% | 0.00% | 0.79% | 12.09% | 3.26% | 5.52% | 7.19% |
Drawdowns
RMQAX vs. BIPIX - Drawdown Comparison
The maximum RMQAX drawdown since its inception was -63.18%, smaller than the maximum BIPIX drawdown of -84.51%. Use the drawdown chart below to compare losses from any high point for RMQAX and BIPIX.
Loading graphics...
Drawdown Indicators
| RMQAX | BIPIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.18% | -84.51% | +21.33% |
Max Drawdown (1Y)Largest decline over 1 year | -25.11% | -19.79% | -5.32% |
Max Drawdown (5Y)Largest decline over 5 years | -63.18% | -54.56% | -8.62% |
Max Drawdown (10Y)Largest decline over 10 years | -63.18% | -54.56% | -8.62% |
Current DrawdownCurrent decline from peak | -24.96% | -15.15% | -9.81% |
Average DrawdownAverage peak-to-trough decline | -13.05% | -36.73% | +23.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.20% | 6.92% | +0.28% |
Volatility
RMQAX vs. BIPIX - Volatility Comparison
The current volatility for Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund (RMQAX) is 11.12%, while ProFunds Biotechnology UltraSector Fund (BIPIX) has a volatility of 13.15%. This indicates that RMQAX experiences smaller price fluctuations and is considered to be less risky than BIPIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RMQAX | BIPIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.12% | 13.15% | -2.03% |
Volatility (6M)Calculated over the trailing 6-month period | 25.22% | 26.85% | -1.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.33% | 42.70% | +4.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.16% | 37.38% | +8.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.29% | 35.34% | +10.95% |